image credit: Freepik

Khosla Ventures’ Alex Morgan on biotech’s challenges and solving drug delivery

February 6, 2024


To hear venture capitalist Alex Morgan tell it, investors shouldn’t be in the business of predicting trends.

“There’s often a public perception that we’re in the prediction game,” said Morgan, a partner at Khosla Ventures who oversees the firm’s biotechnology investments. “We’re not trying to be. As an early-stage venture investor, we’re trying to imagine the possible future and bring resources, people and technology to bear, to shift reality.”

Morgan’s optimistic outlook isn’t too out of place on Silicon Valley’s Sand Hill Road, home to some of the best-known names in venture capital and where Khosla’s offices are located. Headed by entrepreneur Vinod Khosla, the firm has invested in technology companies like DoorDash, Affirm and GitLab, and is expanding in the life sciences.

Read More on Biopharma Dive